EUVIMEDEUVIMED entdecken
Open Access

Survival factors in lung cancer patients with mutations in the PROS1 , SERPINC1 , F2 , and F5 genes

Ryan Brownlee, Aditya Birla, Hung Bui, Raniya Ahmad, Dongyu Zhang, Andrew Ji, Girindra Raval

Oncotarget · 02.11.2026 · 17 (1) · 489-501

DOI: 10.18632/oncotarget.28914 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncotarget, erschienen am 02.11.2026. Verfasst von Ryan Brownlee und 6 weiteren Autor:innen. Hauptthemen laut MEDLINE: Lung Neoplasms, Mutation, Antithrombin III. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsMutationAntithrombin IIIHumansFemaleAgedMaleMiddle AgedThrombophiliaPrognosisNeoplasm StagingProtein S

Stichwörter der Autor:innen

F5PROS1SERPINC1lung cancerthrombophilia

Substanzen

PROS1 protein, humanSERPINC1 protein, humanAntithrombin IIIProtein S

Zitieren

APA

Brownlee, R., Birla, A., Bui, H., Ahmad, R., Zhang, D., Ji, A., & Raval, G. (2026). Survival factors in lung cancer patients with mutations in the PROS1 , SERPINC1 , F2 , and F5 genes. Oncotarget, 17(1), 489-501. https://doi.org/10.18632/oncotarget.28914

Vancouver

Brownlee R, Birla A, Bui H, Ahmad R, Zhang D, Ji A, et al. Survival factors in lung cancer patients with mutations in the PROS1 , SERPINC1 , F2 , and F5 genes. Oncotarget. 2026;17(1):489-501. doi:10.18632/oncotarget.28914

BibTeX
@article{Brownlee2026,
  author = {Brownlee, Ryan and Birla, Aditya and Bui, Hung and Ahmad, Raniya and Zhang, Dongyu and Ji, Andrew and Raval, Girindra},
  title = {Survival factors in lung cancer patients with mutations in the PROS1 , SERPINC1 , F2 , and F5 genes},
  journal = {Oncotarget},
  year = {2026},
  volume = {17},
  number = {1},
  pages = {489--501},
  doi = {10.18632/oncotarget.28914}
}
Kostenlos starten →